This inventor holds 1 USPTO granted patent. Top assignee: Cellectis. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Eustrate Avrameas: Innovator in Amino Acid Sequences
Introduction
Eustrate Avrameas is a notable inventor based in Athens, Greece. He has made significant contributions to the field of biotechnology, particularly in the development of amino acid sequences that enhance cellular penetration of substances.
Latest Patents
Avrameas holds a patent for "Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei." This invention focuses on an amino acid sequence that can facilitate the penetration of substances into cells and cell nuclei. The sequence is characterized by its ability to react in vivo with aminoglycans, and it may optionally be derived from a protein of human origin. He has 1 patent to his name.
Career Highlights
Eustrate Avrameas is currently associated with Cellectis, a company known for its innovative approaches in gene editing and biotechnology. His work at Cellectis has allowed him to explore and develop groundbreaking technologies that have the potential to impact various fields, including medicine and agriculture.
Collaborations
One of his notable coworkers is Therese Ternynck, with whom he has likely collaborated on various projects within the company.
Conclusion
Eustrate Avrameas is a distinguished inventor whose work in amino acid sequences has the potential to revolutionize how substances interact with cells. His contributions to biotechnology continue to pave the way for future innovations.